Tag Archives: SMCxPRO® immunoassay technology

Merck and Michael J. Fox Foundation Collaborate to Advance Parkinson’s Research with Innovative Biomarker Technology

(IN BRIEF) Merck and The Michael J. Fox Foundation (MJFF) are collaborating to advance Parkinson’s disease research using Merck’s SMCxPRO® immunoassay technology. This initiative aims to detect biomarkers indicating cell dysfunction in PD patients, enhancing research into new treatment options … Read the full press release